Global drugmakers operating in Russia will be able to label their drugs directly at customs warehouses in Russia, which will allow them to save on costs and facilitate imports of many of foreign drugs to the Russian market.
That has been recently approved by Russia’s Prime Minister Mikhail Mishustin, reports The Pharma Letter’s local correspondent. The introduction of the measure was part of state efforts for the launch of the all-Russian system of drug labeling.
Starting from July 1 of the current year, all the drugs produced in Russia must be labeled with Data Matrix codes, which means that information about their movement in the retail network will be recorded in the Russian Federal State Information System for Monitoring the Movement of Drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze